Of interest, a subset of samples from patient with CRPC (adenocarcinoma) did exhibit medium-to-high levels of MYBL2 (Fig. 2B); however, overall MYBL2 expression was significantly increased in NEPC samples. Here, MYBL2 is linked to adenocarcinoma.